Nov 11th, 2021
Clinical Interest Article
Nov 11th, 2021
Clinical Interest Article
EROSION III—coverage of TCT 2021
A randomized trial of OCT-guided intervention in STEMI patients with early infarct artery patency.
Nov 11th, 2021
Clinical Interest Article
iFR-SWEDEHEART—coverage of TCT 2021
Five-year outcomes of a randomized trial of iFR-guided vs. FFR-guided PCI.
Nov 11th, 2021
Clinical Interest Article
MASTER-DAPT—coverage of TCT 2021
A randomized trial of abbreviated antiplatelet therapy outcomes in high bleeding risk patients with high thrombotic and ischemic risk.
Aug 5th, 2021
Clinical Interest Article
Hospital-Level Percutaneous Coronary Intervention Performance with Simulated Risk-Avoidance Strategies—coverage of late-breaking science at SCAI 2021 Scientific Sessions
While some hospitals might be tempted to improve their performance rankings by refusing to treat the highest-risk patients, this strategy “is irrational” ...
Aug 5th, 2021
Clinical Interest Article
Comparison of the ISCHEMIA Trial Population to Patients Undergoing PCI in US Practice: A CathPCI National Cardiovascular Data Registry (NCDR) Research to Practice (R2P) Initiative—coverage of late-breaking science at SCAI 2021 Scientific Sessions
The population represented in the ISCHEMIA trial for stable ischemic heart disease (SIHD) – which commonly informs contemporary decision-making – does not...
Jul 30th, 2021
Clinical Interest Article
SCAI Shock Classification for Mortality Risk Stratification: Survey of Published Evidence—coverage of late-breaking science at SCAI 2021 Scientific Sessions
SCAI’s recent cardiogenic shock classification system has been confirmed as effective in mortality risk stratification in a new study of more than 15,000 ...
Jul 6th, 2021
Clinical Interest Article
Radial hemostasis and early TR Band deflation is safer and faster with a potassium ferrate hemostatic patch (StatSeal)—coverage of late-breaking science at SCAI 2021 Scientific Sessions
Results from the randomized controlled StatSeal with TR Band Assessment Trial 2 (STAT2)
The use of a potassium ferrate hemostatic patch in addition to T...
Jul 5th, 2021
Clinical Interest Article
Establishing the Optimal Duration of DAPT After PCI in High Risk TWILIGHT-like Patients with ACS—coverage of late-breaking science at SCAI 2021 Scientific Sessions
Prolonged dual antiplatelet therapy (DAPT) should remain the standard of care for high-risk acute coronary syndrome (ACS) patients after percutaneous coro...
Jul 2nd, 2021
Clinical Interest Article
Update on the North American COVID-19 Myocardial Infarction (NACMI) Registry—coverage of late-breaking science at SCAI 2021 Scientific Sessions
Primary percutaneous coronary intervention (PCI) and being younger in age were both protective against death in COVID-19-positive patients with ST-segment...